Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide Regeneration

NCT05296317 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

97

Enrollment

OTHER

Sponsor class

Conditions

Localized Breast Cancer

Interventions

DRUG: Dense dose epirubicin-cyclophosphamide chemotherapy and G-CSF (filgrastim, lenograstim)
DRUG: Dense dose epirubicin-cyclophosphamide chemotherapy with administration of peg-G-CSF (pegfilgrastim)

Sponsor

Centre Georges Francois Leclerc